Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Genome Editing | Q&As & Interviews

Recent Advances and the Future Landscape of Genome Editing For Disease Models And How This Has Helped Us Gain Insight Into Disease Biology 

01 March 2023
In Conversation With Laralynne Pryzbyla, Adjunct Assistant Professor at UCSF & UC Scientific Director, Laboratory for Genomics Research

In this video Q&A we discuss the recent advances in the landscape of genome editing for disease modelling. Topics include the developments in the genome editing landscape, the limitations and necessity of iPSC disease models, CRISPRi & CRISPRa for functional genomics and new insights gene editing has uncovered in disease biology. 

Laralynne will be joining us again at Oxford Global’s NextGen Omics US: In-Person, as part of a 6th Annual Genome Editing Congress. She will be presenting in March on Next-Generation CRISPR Screening Platforms For Insights Into Human Disease Biology. 

https://youtu.be/CQXuu7sQ1CA

Speaker Biographies

Laralynne Przybyla, PhD, is an Adjunct Assistant Professor at UCSF and UC Scientific Director at the Laboratory for Genomics Research, a joint industry-academia hybrid institute between UCSF, UC Berkeley, and GSK. Her research has focused on cell and developmental biology, including building human iPSC-based models to uncover the molecular basis of developmental processes and disease states. Dr. Przybyla obtained her PhD in Biology from MIT and has experience leading technology development teams in both academia and industry. At the LGR, Laralynne leads the UC team to develop and implement new CRISPR-based functional genomics models, tools, and platforms, with the goal of creating and disseminating next-generation technologies and furthering our understanding of the mechanisms and genetics underlying human disease biology. 

 

Related Resources

The Applications of CRISPR in Optimising Animal Models for Human Disease Research 

CRISPR-based animal models expedite drug development by enhancing accuracy, replicating human physiology, reducing time and cost, aiding in predicting treatment efficacy, and addressing safety concerns in clinical trials.
Read More

Celebrating the Achievements of Barbara McClintock, Discoverer of Mobile Genetic Elements and Gene Transposition

To date, 114 Nobel Prizes in Physiology or Medicine have been awarded to 226 laureates. Of these laureates, just 12 have been women. This article looks at one of those 12 women and celebrates her contributions to the field of genetics. Her name is Barbara McClintock.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
17/06/24
Bringing CRISPR/Cas9 Approaches To The Clinic: The Example Of Beta-Hemoglobinopathies